Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Evaluating IL-21 as a Potential Therapeutic Target in Crohn's Disease.

Holm TL, Tornehave D, Søndergaard H, Kvist PH, Sondergaard BC, Hansen L, Hermit MB, Holgersen K, Vergo S, Frederiksen KS, Haase C, Lundsgaard D.

Gastroenterol Res Pract. 2018 Apr 10;2018:5962624. doi: 10.1155/2018/5962624. eCollection 2018.

2.

Detection of gene expression signatures related to underlying disease and treatment in rheumatoid arthritis patients.

Serikawa KA, Jacobsen S, Lundsgaard D, Fox BA, Hummelshoj L, Poulsen LK, Fleckner J, Frederiksen KS.

Mod Rheumatol. 2013 Jul;23(4):729-40. doi: 10.1007/s10165-012-0723-9. Epub 2012 Aug 8. Erratum in: Mod Rheumatol. 2013 Jul;23(4):741.

PMID:
22872428
3.

Increased serum β2-microglobulin is associated with clinical and immunological markers of disease activity in systemic lupus erythematosus patients.

Hermansen ML, Hummelshøj L, Lundsgaard D, Hornum L, Keller P, Fleckner J, Fox B, Poulsen LK, Jacobsen S.

Lupus. 2012 Sep;21(10):1098-104. doi: 10.1177/0961203312447668. Epub 2012 May 10.

PMID:
22577117
4.

Clinical and biological efficacy of recombinant human interleukin-21 in patients with stage IV malignant melanoma without prior treatment: a phase IIa trial.

Davis ID, Brady B, Kefford RF, Millward M, Cebon J, Skrumsager BK, Mouritzen U, Hansen LT, Skak K, Lundsgaard D, Frederiksen KS, Kristjansen PE, McArthur G.

Clin Cancer Res. 2009 Mar 15;15(6):2123-9. doi: 10.1158/1078-0432.CCR-08-2663. Epub 2009 Mar 10.

5.

Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin.

Johansen C, Usher PA, Kjellerup RB, Lundsgaard D, Iversen L, Kragballe K.

Br J Dermatol. 2009 Feb;160(2):319-24. doi: 10.1111/j.1365-2133.2008.08902.x. Epub 2008 Oct 21.

PMID:
19016708
6.

Immune activation in advanced cancer patients treated with recombinant IL-21: multianalyte profiling of serum proteins.

Dodds MG, Frederiksen KS, Skak K, Hansen LT, Lundsgaard D, Thompson JA, Hughes SD.

Cancer Immunol Immunother. 2009 Jun;58(6):843-54. doi: 10.1007/s00262-008-0600-8. Epub 2008 Oct 17.

PMID:
18925392
7.

IL-21 induces in vivo immune activation of NK cells and CD8(+) T cells in patients with metastatic melanoma and renal cell carcinoma.

Frederiksen KS, Lundsgaard D, Freeman JA, Hughes SD, Holm TL, Skrumsager BK, Petri A, Hansen LT, McArthur GA, Davis ID, Skak K.

Cancer Immunol Immunother. 2008 Oct;57(10):1439-49. doi: 10.1007/s00262-008-0479-4. Epub 2008 Feb 20.

8.

Interleukin-21 activates human natural killer cells and modulates their surface receptor expression.

Skak K, Frederiksen KS, Lundsgaard D.

Immunology. 2008 Apr;123(4):575-83. Epub 2007 Nov 14.

9.

PolyI:C induction of diabetes is controlled by Iddm4 in rats with a full regulatory T cell pool.

Hornum L, Lundsgaard D, Markholst H.

Ann N Y Acad Sci. 2007 Sep;1110:65-72.

PMID:
17911421
10.

An open-label, two-arm, phase I trial of recombinant human interleukin-21 in patients with metastatic melanoma.

Davis ID, Skrumsager BK, Cebon J, Nicholaou T, Barlow JW, Moller NP, Skak K, Lundsgaard D, Frederiksen KS, Thygesen P, McArthur GA.

Clin Cancer Res. 2007 Jun 15;13(12):3630-6.

11.

Flow sorting from organ material by intracellular markers.

Moerch U, Nielsen HS, Lundsgaard D, Oleksiewicz MB.

Cytometry A. 2007 Jul;71(7):495-500.

12.

Inhibition of NKG2D receptor function by antibody therapy attenuates transfer-induced colitis in SCID mice.

Kjellev S, Haase C, Lundsgaard D, Ursø B, Tornehave D, Markholst H.

Eur J Immunol. 2007 May;37(5):1397-406.

14.

Reconstitution of Scid mice with CD4+CD25- T cells leads to rapid colitis: an improved model for pharmacologic testing.

Kjellev S, Lundsgaard D, Poulsen SS, Markholst H.

Int Immunopharmacol. 2006 Aug;6(8):1341-54. Epub 2006 May 23.

PMID:
16782548
15.

Reactivity of naive CD4+CD25- T cells against gut microflora in healthy mice.

Gad M, Lundsgaard D, Kjellev S, Kristensen NN, Seremet T, Straten PT, Claesson MH.

Int Immunol. 2006 May;18(5):817-25. Epub 2006 Mar 30.

PMID:
16574668
16.

In vivo control of diabetogenic T-cells by regulatory CD4+CD25+ T-cells expressing Foxp3.

Lundsgaard D, Holm TL, Hornum L, Markholst H.

Diabetes. 2005 Apr;54(4):1040-7.

17.

Improved beta-cell survival and reduced insulitis in a type 1 diabetic rat model after treatment with a beta-cell-selective K(ATP) channel opener.

Skak K, Gotfredsen CF, Lundsgaard D, Hansen JB, Sturis J, Markholst H.

Diabetes. 2004 Apr;53(4):1089-95.

18.
19.

An F344 rat congenic for BB/DP rat-derived diabetes susceptibility loci Iddm1 and Iddm2.

Hornum L, Lundsgaard D, Markholst H.

Mamm Genome. 2001 Nov;12(11):867-8. No abstract available.

PMID:
11845290
20.

Restoration of strong grasp and lateral pinch in tetraplegia due to cervical spinal cord injury.

House JH, Gwathmey FW, Lundsgaard DK.

J Hand Surg Am. 1976 Sep;1(2):152-9.

PMID:
1018080

Supplemental Content

Loading ...
Support Center